AU2002364783A8 - Purified polypeptides involved in general metabolism - Google Patents

Purified polypeptides involved in general metabolism

Info

Publication number
AU2002364783A8
AU2002364783A8 AU2002364783A AU2002364783A AU2002364783A8 AU 2002364783 A8 AU2002364783 A8 AU 2002364783A8 AU 2002364783 A AU2002364783 A AU 2002364783A AU 2002364783 A AU2002364783 A AU 2002364783A AU 2002364783 A8 AU2002364783 A8 AU 2002364783A8
Authority
AU
Australia
Prior art keywords
purified polypeptides
polypeptides involved
general metabolism
metabolism
general
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002364783A
Other versions
AU2002364783A1 (en
Inventor
Megan Domagala
Benjamin Pinder
Masoud Vedadi
Sasha Necakov
Ivy Ng
Olga Wrezel
Muhammad Zahoor Alam
Kathleen Nethery
Francois Vallee
Simon Houston
Donald Awrey
Bryan Beattie
Aled Edwards
Bay Sheldrick
Kamran Mansoury
Akil Dharamsi
Veronica Canadien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affinium Pharmaceuticals Inc
Original Assignee
Affinium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affinium Pharmaceuticals Inc filed Critical Affinium Pharmaceuticals Inc
Publication of AU2002364783A1 publication Critical patent/AU2002364783A1/en
Publication of AU2002364783A8 publication Critical patent/AU2002364783A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1085Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2299/00Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002364783A 2001-11-21 2002-11-21 Purified polypeptides involved in general metabolism Abandoned AU2002364783A1 (en)

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US33216001P 2001-11-21 2001-11-21
US60/332,160 2001-11-21
US33366501P 2001-11-27 2001-11-27
US33366101P 2001-11-27 2001-11-27
US60/333,665 2001-11-27
US60/333,661 2001-11-27
US34177001P 2001-12-18 2001-12-18
US60/341,770 2001-12-18
US34200301P 2001-12-19 2001-12-19
US34195401P 2001-12-19 2001-12-19
US60/342,003 2001-12-19
US60/341,954 2001-12-19
US34254201P 2001-12-20 2001-12-20
US60/342,542 2001-12-20
US34425201P 2001-12-21 2001-12-21
US60/344,252 2001-12-21
US34360601P 2001-12-28 2001-12-28
US34367901P 2001-12-28 2001-12-28
US34357001P 2001-12-28 2001-12-28
US60/343,606 2001-12-28
US60/343,570 2001-12-28
US60/343,679 2001-12-28
PCT/CA2002/001768 WO2003044185A2 (en) 2001-11-21 2002-11-21 Purified polypeptides involved in general metabolism

Publications (2)

Publication Number Publication Date
AU2002364783A1 AU2002364783A1 (en) 2003-06-10
AU2002364783A8 true AU2002364783A8 (en) 2003-06-10

Family

ID=27582776

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002364783A Abandoned AU2002364783A1 (en) 2001-11-21 2002-11-21 Purified polypeptides involved in general metabolism

Country Status (2)

Country Link
AU (1) AU2002364783A1 (en)
WO (1) WO2003044185A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2939538T3 (en) 2008-07-03 2019-05-31 Monsanto Technology Llc Combinations of derivatized saccharide surfactants and etheramine oxide surfactants as herbicide adjuvants
EP2550289A4 (en) 2010-03-12 2013-11-27 Childrens Medical Center Novel immunogens and methods for discovery and screening thereof
EP4272750A3 (en) 2013-02-07 2024-01-24 Children's Medical Center, Corp. Protein antigens that provide protection against pneumococcal colonization and/or disease
KR20210093854A (en) 2018-09-12 2021-07-28 아피니백스, 인크. polyvalent pneumococcal vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037123A (en) * 1995-09-15 2000-03-14 Microcide Pharmaceuticals, Inc. Methods of screening for compounds active on Staphylococcus aureus target genes
WO2001021769A2 (en) * 1999-09-23 2001-03-29 Mcgill University THREE-DIMENSIONAL STRUCTURE AND CRYSTAL OF A CLASS I α1,2-MANNOSIDASE, AND METHODS OF USE THEREOF
MXPA02008253A (en) * 2000-02-25 2002-11-29 Wyeth Corp Methods of structure based drug design using ms nmr.
EP1272845A4 (en) * 2000-03-28 2003-09-10 Wyeth Corp SOLUTION AND CRYSTAL STRUCTURES OF ZipA AND ZipA COMPLEX AND USES THEREOF
WO2001079457A2 (en) * 2000-04-13 2001-10-25 University Health Network Crystal structure for rmlc and uses thereof
EP1158000A1 (en) * 2000-05-23 2001-11-28 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Crystal structure data of cystalysin and use thereof for the design and preparation of inhibitor molecules

Also Published As

Publication number Publication date
AU2002364783A1 (en) 2003-06-10
WO2003044185A2 (en) 2003-05-30
WO2003044185A3 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
GB2371027B (en) Improvements in bicycles
GB0110544D0 (en) Improvements in substrates
GB0101153D0 (en) Improvement in the structure of a screw
GB0127466D0 (en) Improvements in footwear
GB0105667D0 (en) Improvements in insulating materials
EP1501722A4 (en) Improvements in bowsprits
AU2002364783A8 (en) Purified polypeptides involved in general metabolism
GB2374882B (en) Improvements in roof supports
AU2002301358A1 (en) Improvements in Transmissometers
AU2002301354A1 (en) Improvements in Transmissometers
AU2003281877A8 (en) Novel purified polypeptides involved in metabolism
AU2003213935A8 (en) Novel purified polypeptides involved in cellular metabolism
AU2002328223A1 (en) Purified polypeptides involved in co-factor metabolism
GB0118126D0 (en) Improvements in or relating to vapourisers
AU2002364771A8 (en) Purified polypeptides involved in general metabolism as possible drug targets
AU2002364770A8 (en) Purified polypeptides involved in carbohydrate and coenzyme metabolism
GB0128167D0 (en) Improvements in keyboards
GB2379887B (en) Improvements in slides
GB0107971D0 (en) Improvements in visible passes
GB0116220D0 (en) Improvements in fasteners
GB0114432D0 (en) Improvements in fasteners
GB0123487D0 (en) Two in one
GB0205241D0 (en) Five in one
AUPR473801A0 (en) Improvements in components
GB0124786D0 (en) Improvements in transportation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase